Stroke: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Peter A. Lipson
imported>Peter A. Lipson
No edit summary
Line 53: Line 53:
*Atherosclerosis: many of the risk factors listed below are also risk factors for atherosclerosis.  Other marker for atherosclerosis include [[peripheral artery disease]] and [[coronary artery disease]].
*Atherosclerosis: many of the risk factors listed below are also risk factors for atherosclerosis.  Other marker for atherosclerosis include [[peripheral artery disease]] and [[coronary artery disease]].
*Hypertension is the most powerful risk factor for ischemic stroke, and the primary risk factor for intracerebral hemorrhagic stroke. <ref name=ALLHAT>ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA. 288(23):2981-97, 2002 Dec 18.</ref><ref name=Framingham>Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: Estimates from the Framingham study. Stroke.  2006; 37: 345–350</ref>
*Hypertension is the most powerful risk factor for ischemic stroke, and the primary risk factor for intracerebral hemorrhagic stroke. <ref name=ALLHAT>ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA. 288(23):2981-97, 2002 Dec 18.</ref><ref name=Framingham>Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: Estimates from the Framingham study. Stroke.  2006; 37: 345–350</ref>
*Smoking: cigarette smoking significantly increases stroke risk, and the risk is dependent on the amount of smoking.  Risk decreases significantly 2 years after quitting cigarettes.<ref>Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA.  1988; 259: 1025–1029</ref>Cigar and pipe smoke also increase stroke risk but to a lesser degree.
*Smoking: cigarette smoking significantly increases stroke risk, and the risk is dependent on the amount of smoking.<ref>Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA.  1988; 259: 1025–1029</ref>Cigar and pipe smoke also increase stroke risk but to a lesser degree.
*Transient Ischemic Attack: Occurrence of TIA is a strong risk factor for stroke.  In one study, 5% of patients with TIA developed stroke within 2 days, 10% within 90 days.<ref>Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA.  2000; 284: 2901–2906</ref> TIA should be considered a medical emergency; rapid response reduces the risk of stroke.
*Transient Ischemic Attack: Occurrence of TIA is a strong risk factor for stroke.  In one study, 5% of patients with TIA developed stroke within 2 days, 10% within 90 days.<ref>Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA.  2000; 284: 2901–2906</ref> TIA should be considered a medical emergency; rapid response reduces the risk of stroke.
*[[Atrial Fibrillation]] (AF): The average yearly risk for stroke in untreated AF is 5%, but can be as high as 12%.<ref>Hylek E. M., Go A. S., Chang Y., Jensvold N. G., Henault L. E., Selby J. V., Singer D. E. N Engl J Med 2003; 349:1019-1026, Sep 11, 2003</ref> This can be significantly reduced with the use of oral anticoagulants (i.e. warfarin).
*[[Atrial Fibrillation]] (AF): The average yearly risk for stroke in untreated AF is 5%, but can be as high as 12%.<ref>Hylek E. M., Go A. S., Chang Y., Jensvold N. G., Henault L. E., Selby J. V., Singer D. E. N Engl J Med 2003; 349:1019-1026, Sep 11, 2003</ref> This can be significantly reduced with the use of oral anticoagulants (i.e. warfarin).
Line 90: Line 90:
Prevention of stroke involves reducing modifiable risk factors, and falls broadly into two categories: prevention of first stroke (primary prevention), and prevention of further strokes (secondary prevention).
Prevention of stroke involves reducing modifiable risk factors, and falls broadly into two categories: prevention of first stroke (primary prevention), and prevention of further strokes (secondary prevention).
*Keeping blood pressure below 120/80 reduces the risk of both primary and recurrent stroke.<ref name=ALLHAT>ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA. 288(23):2981-97, 2002 Dec 18.</ref><ref name=Framingham>Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: Estimates from the Framingham study. Stroke.  2006; 37: 345–350</ref>
*Keeping blood pressure below 120/80 reduces the risk of both primary and recurrent stroke.<ref name=ALLHAT>ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA. 288(23):2981-97, 2002 Dec 18.</ref><ref name=Framingham>Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: Estimates from the Framingham study. Stroke.  2006; 37: 345–350</ref>
 
*Quitting smoking decreases risk significantly 2 years after quitting cigarettes.<ref>Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA.  1988; 259: 1025–1029</ref>
==References==
==References==
<references/>
<references/>

Revision as of 12:09, 1 May 2007

A stroke (syn. Cerebral Vascular Accident or "CVA") is a sudden, often focal, loss of brain function. The term "cerebral vascular accident" refers to some of the most essential features of the underlying cause and the nature of a stroke: (1) "cerebral "indicates that the brain is involved (2) "vascular" indicates that the blood vessels are involved and (3) "accident" indicates that this is a rapid and detrimental occurance in the body. Although most strokes in people do involve the higher centers of the brain that are located in the cerebral hemispheres; the word cerebral is not strictly accurate, as some strokes can involve only the lower portions of the brain, like the medulla oblongata or other areas of the brain stem. Most stroke experts prefer the term "stroke" to "CVA".

There are many different causes of stroke, but whenever a stroke occurs, there has been an interruption of the normal bood supply to brain cells. When that interruption is long enough, it causes death of brain cells. The symptoms and signs of disease that are caused by the death of brain stems is highly dependant upon the number of cells that are affected, and exactly where they are located in the brain. Accordingly, strokes can have many different clinical presentations - ranging from deep coma with the loss of the ability to breathe to very limited deficits in the ability to move a part of the body or changes in perception like partial blindness from a restriction in visual field. The interuption of normal blood circulation to the brain, or to limited and specific areas of the brain, generally comes about either because blood flow is stopped (occluded) within the blood vessel, or because the blood vessel ruptures (hemorrhages) and no longer serves to supply the brain cells with nutrients and oxygen floods the blood it carries into a damaging clot that both starves and puts pressure on these cells.

Epidemiology

Stroke is one of the leading causes of long term disabilty, and of death, in the developed world. Approximately 700,000 Americans per year experience a stroke. It is the third leading cause of death and the leading cause of long-term adult disability in the United States.[1] On average, a stroke occurs every 45 seconds and someone dies from a stroke every 3 minutes.[2][3]

Risk factors for stroke include atherosclerosis, advanced age, hypertension (high blood pressure), diabetes mellitus, high cholesterol, cigarette smoking, atrial fibrillation, ethnic identity, and some blood clotting disorders.

The term "brain attack" has been advocated for use in the United States for stroke, just as the term "heart attack" is used for myocardial infarction. Many hospitals have multidisciplinary "stroke teams" specifically for swift treatment of stroke.

A transient ischemic attack (TIA) is a brief loss of neurologic function, and is discussed elsewhere.

Strokes can be classified as ischemic or hemorrhagic.

Etiology

Ischemic Stroke

Atherosclerosis is responsible for the majority of ischemic strokes. Atheroembolism can occur within the cerebral circulation or can originate outside the cerebral circulation. The etiology of atherosclerosis-related strokes is very similar to that of heart attacks. An atherosclerotic plaque in a cerebral artery can gradually develop an associated thrombus or rupture suddenly causing a rapid occlusion, or the thrombus can break off and lodge in a vessel even deeper in the brain. "Thrombotic stroke" usually refers to in-situ thrombus, "embolic stroke" to thrombi that travel from distant sites.

Thrombotic Stroke

Thrombotic and thromboembolic strokes can originate in either large or small blood vessels, and are usually due to abnormalities in the vessel (most commonly atherosclerosis). One of the most important etiologies is carotid artery disease. Lacunae are also a subset of thrombotic stroke.

Embolic Stroke

Embolism of thrombi from outside the cerebral circulation are responsible for a large and important subset of ischemic strokes. In these cases a thrombus (blood clot) travels from its origin and lodges in a cerebral artery. Most of these strokes are of cardiac origin (Cardioembolic).

Cardioembolic Stroke
  • Atrial fibrillation: The majority of embolic strokes originating in the heart are due to atrial fibrillation. In fact, about 16% of strokes are associated with atrial fibrillation, and the presence of atrial fibrillation increases stroke risk by about 5-11% per year, depending on other risk factors. [5]The relative stasis of blood in the left atrium leads to blood clot formation, and these clots can be expelled from the heart to enter the cerebral circulation.
  • Mural thrombi: anything that causes blood flow in the heart to slow can cause thrombus formation. This includes thrombi formed in the atrial appendage and thrombi formed in the left ventricle in patients with heart failure.
  • Valvular heart disease: this includes rheumatic heart disease, infective endocarditis, and presence of a prosthetic heart valve.
  • Paradoxical embolism: this occurs primarily when a deep venous thrombosis (DVT) in the leg breaks off, passing through a patent foramen ovale (PFO) into the left ventricle, and then to the brain.

Systemic hypoperfusion (Watershed stroke)

Systemic hypoperfusion is the reduction of blood flow to all parts of the body. It is most commonly due to various types of shock. Hypoxemia (low blood oxygen content) may precipitate the hypoperfusion. Because the reduction in blood flow is global, all parts of the brain may be affected, especially "watershed" areas --- border zone regions supplied by the major cerebral arteries. Blood flow to these areas does not necessarily stop, but instead it may lessen to the point where brain damage can occur.

Hemorrhagic stroke

A hemorrhagic stroke, or cerebral hemorrhage, is a form of stroke that occurs when a blood vessel in the brain ruptures or bleeds. There are two types of hemorrhagic stroke: intracerebral hemorrhage, and subarachnoid hemorrhage (SAH). Traumatic hemorrhage, including epidural hemorrhage, subdural hemorrhage, and some SAH are usually considered separately.

Intracerebral hemorrhage

Intracerebral hemorrhage (ICH) is bleeding directly into the brain tissue, forming a gradually enlarging hematoma (pool of blood). It generally occurs in small arteries or arterioles and is commonly due to hypertension, trauma, and vascular malformations. The hematoma enlarges until pressure from surrounding tissue limits its growth, or until it decompresses by emptying into the ventricular system. ICH has a mortality rate of 44 percent after 30 days, higher than ischemic stroke or even the very deadly subarachnoid hemorrhage.[6]

Subarachnoid hemorrhage

Subarachnoid hemorrhage (SAH) is bleeding into the cerebrospinal fluid (CSF) surrounding the brain. The two most common causes of SAH are rupture of aneurysms and bleeding from vascular malformations. Bleeding into the CSF from a ruptured aneurysm occurs very quickly, causing rapidly increased intracranial pressure. The initial bleed can be brief, but rebleeding is common. Death or deep coma ensues if the bleeding continues. SAH has a 37-45% mortality for patients 45 and older.[7][8]

Risk Factors[9]

  • Previous stroke
  • Atherosclerosis: many of the risk factors listed below are also risk factors for atherosclerosis. Other marker for atherosclerosis include peripheral artery disease and coronary artery disease.
  • Hypertension is the most powerful risk factor for ischemic stroke, and the primary risk factor for intracerebral hemorrhagic stroke. [10][11]
  • Smoking: cigarette smoking significantly increases stroke risk, and the risk is dependent on the amount of smoking.[12]Cigar and pipe smoke also increase stroke risk but to a lesser degree.
  • Transient Ischemic Attack: Occurrence of TIA is a strong risk factor for stroke. In one study, 5% of patients with TIA developed stroke within 2 days, 10% within 90 days.[13] TIA should be considered a medical emergency; rapid response reduces the risk of stroke.
  • Atrial Fibrillation (AF): The average yearly risk for stroke in untreated AF is 5%, but can be as high as 12%.[14] This can be significantly reduced with the use of oral anticoagulants (i.e. warfarin).
  • Diabetes mellitus [15][16]The role of good blood sugar control in the prevention of stroke in diabetics is still being investigated. Aggressive treatment of cholesterol and blood pressure in diabetics is essential.
  • High Cholesterol: treatment of high cholesterol and other blood lipid disorders reduces the rate of first stroke and recurrent stroke. [17]
  • Age: the risk of stroke in adults increases significantly over the age of 55, and continues to increase thereafter.
  • Ethnicity: African Americans have twice the risk of a first stroke as whites.
  • Carotid stenosis (asymptomatic)
  • Cocaine: cocaine use is a significant risk for stroke and heart attack.
  • Blood disorders (e.g. sickle-cell disease, anti-cardiolipin syndrome)
  • Estrogen: recent studies have found small but significant increase in stroke risk in women receiving hormone replacement therapy (HRT). In one large study, stroke risk was increase by 55%, which equates to 12 additional strokes per 10,000 person-years.[18] Oral contraceptive pills (OCPs) may confer some risk, especially when combined with other risks such as smoking, however the risk from the currently used low-dose OCPs is quite low.[19]
  • Pregnancy: there is a small but significant increase in stroke risk during, and just after pregnancy.

Symptoms

The symptoms of stroke depend on what part of the brain is affected. A friend or family member may be the first to notice. Symptoms can include:

  • Sudden numbness or weakness of the face, arm, or leg, especially one-sided
  • Sudden confusion, trouble speaking, or trouble understanding
  • Sudden trouble walking, dizziness, or loss of balance or coordination
  • Sudden trouble seeing in 1 or both eyes
  • Sudden severe headache
  • Difficulty swallowing or drooling

Diagnosis

A stroke is diagnosed first by a medical professional taking a proper history and physical exam. Addtional tests include:

  • Computed tomography (CT) scan
  • Magnetic resonance imaging (MRI)
  • Cerebral angiography

Treatment

Stroke is a 'medical emergency.' Permanent neurologic damage or death can sometimes be avoided, but only if stroke is promptly diagnosed and treated.

Presentation to a specialized stroke center within 3 hours of the start of symptoms may allow for the reversal of the stroke by adminstration by clot-disolving medications.

Prevention

Prevention of stroke involves reducing modifiable risk factors, and falls broadly into two categories: prevention of first stroke (primary prevention), and prevention of further strokes (secondary prevention).

  • Keeping blood pressure below 120/80 reduces the risk of both primary and recurrent stroke.[10][11]
  • Quitting smoking decreases risk significantly 2 years after quitting cigarettes.[20]

References

  1. Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health conditions among adults: United States, 1999. MMWR Morb Mortal Wkly Rep. 2001; 50: 120–125
  2. Circulation. 2007;115:e69-e171.
  3. http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA.106.179918
  4. Goldman: Cecil Textbook of Medicine, 22nd ed., Copyright © 2004 W. B. Saunders Company
  5. Robert G. Hart, MD Jonathan L. Halperin, MD. Atrial Fibrillation and Stroke Concepts and Controversies. Stroke. 2001;32:803.
  6. Caplan LR (1992). "Intracerebral hemorrhage". Lancet 339 (8794): 656-8. PMID 1347346.
  7. El-Saed A, Kuller LH, Newman AB, Lopez O, Costantino J, McTigue K, Cushman M, Kronmal R. Geographic variations in stroke incidence and mortality among older populations in four US communities. Stroke. 2006; 37: 1975–1979.
  8. Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, Copper LS, Shahar E. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerotic Risk in Communities (ARIC) Cohort. Stroke. 1999; 30: 736–743
  9. Goldstein LB. Adams R. Alberts MJ. Appel LJ. Brass LM. Bushnell CD. Culebras A. DeGraba TJ. Gorelick PB. Guyton JR. Hart RG. Howard G. Kelly-Hayes M. Nixon JV. Sacco RL. American Heart Association. American Stroke Association Stroke Council. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group.Circulation. 113(24):e873-923, 2006 Jun 20
  10. 10.0 10.1 ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).JAMA. 288(23):2981-97, 2002 Dec 18.
  11. 11.0 11.1 Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: Estimates from the Framingham study. Stroke. 2006; 37: 345–350
  12. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA. 1988; 259: 1025–1029
  13. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000; 284: 2901–2906
  14. Hylek E. M., Go A. S., Chang Y., Jensvold N. G., Henault L. E., Selby J. V., Singer D. E. N Engl J Med 2003; 349:1019-1026, Sep 11, 2003
  15. Timothy M. E. Davis, FRACP; Helen Millns, PhD; Irene M. Stratton, MSc; Rury R. Holman, FRCP; Robert C. Turner, MD, FRCP; for the UK Prospective Diabetes Study Group. Risk Factors for Stroke in Type 2 Diabetes Mellitus, United Kingdom Prospective Diabetes Study (UKPDS) 29 Arch Intern Med. 1999;159:1097-1103.
  16. PA Wolf, RB D'Agostino, AJ Belanger and WB Kannel Probability of stroke: a risk profile from the Framingham Study. Stroke, Vol 22, 312-318
  17. Stroke.Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors.Blauw GJ, Lagaay AM, Smelt AH, Westendorp RG.1997 May;28(5):946-50. PMID: 9158630
  18. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J, WHI investigators. Effects of conjugated equine estrogen on stroke in the Women’s Health Initiative. Circulation. 2006; 113: 2425–2434
  19. Sasitorn Siritho, MD; Amanda G. Thrift, PhD; John J. McNeil, PhD; Roger X. You, PhD; Stephen M. Davis, MD Geoffrey A. Donnan, MD. Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill. The Melbourne Risk Factor Study (MERFS) Group. Stroke, Vol 22, 312-318
  20. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham study. JAMA. 1988; 259: 1025–1029

External Links

  1. http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA.106.179918
  2. http://www.cdc.gov/stroke/
  3. http://www.strokeassociation.org/presenter.jhtml?identifier=1200037
  4. http://www.nlm.nih.gov/medlineplus/ency/article/000726.htm

Further Reading